
MSD Collaborates with I-Mab to Evaluate Keytruda + TJC4 for Multiple Cancer Indications
Shots: MSD to supply Keytruda (pembrolizumab) to I-Mab to utilize it in clinical studies in combination with its TJC4. The companies will collaborate
[Read More...]